Orange Book product · Brand (NDA)

EMEND

FOSAPREPITANT DIMEGLUMINE

Brand (NDA)NDA 022023DISCN MERCK AND CO INC

View FOSAPREPITANT DIMEGLUMINE family Open on FDA Orange Book

At a glance

Jan 25, 2008

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

Approval
FDA approval date of this drug product.
Jan 25, 2008
18 yr 8 mo ago
Today

Pharmaceutical detail

Active ingredient

FOSAPREPITANT DIMEGLUMINE

Strength

EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

POWDER

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 022023

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo